Tempest TherapeuticsTPST
13F holders, Q2 2026 (June 30)1holders
0new positions
0sold out
$1.11avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Tempest Therapeutics Inc. (TPST) in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holder was Versant Venture Management, LLC ($299K).
- Company
- Tempest Therapeutics Inc.
- CUSIP
- 87978U108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Versant Venture Management, LLC | 0.18% | No change | 269,772 | $299K |
"% of holder's portfolio" is TPST's weight in each manager's 13F, not the share of Tempest Therapeutics Inc. the manager owns.